Metabolic diseases, such as obesity and diabetes, increase oxidative stress through mechanisms that include advanced glycation end-product (AGE) deposition, activation of protein kinase C (PKC), and dysregulation of the mammalian target of rapamycin (mTOR) signaling pathway. This evidence concerns the gene MTOR and metabolic disease.